NEUROPATHOLOGY CORE

$215,271P30FY2013AGNIH

Oregon Health & Science University, Portland OR

Investigators

Linked publications & trials

Paper 39737610 Paper 39677464 Paper 39379761 Paper 39254167 Paper 39207439 Paper 39173101 Paper 38980643 Paper 38958543 Paper 38958117 Paper 38949538 Paper 38915636 Paper 38883718 Paper 38861052 Paper 38721926 Paper 38712163 Paper 38641585 Paper 38460116 Paper 38441951 Paper 38425303 Paper 38423160 Paper 38418871 Paper 38244935 Paper 38194584 Paper 37592813 Paper 37580727 Paper 37528055 Paper 37491248 Paper 37474615 Paper 37322115 Paper 37289845 Paper 37260021 Paper 37245492 Paper 37212114 Paper 37057867 Paper 37051669 Paper 37038809 Paper 36997127 Paper 36970907 Paper 36946449 Paper 36840665 Paper 36722399 Paper 36710669 Paper 36681388 Paper 36648159 Paper 36628434 Paper 36621368 Paper 36617779 Paper 36577280 Paper 36565204 Paper 36530083 Paper 36482861 Paper 36419636 Paper 36394443 Paper 36343095 Paper 36324086 Paper 36314203 Paper 36308307 Paper 36264254 Paper 36253382 Paper 36251929 Paper 36220593 Paper 36208222 Paper 36189595 Paper 36178120 Paper 36097795 Paper 36093697 Paper 36062452 Paper 36054513 Paper 36031904 Paper 36031892 Paper 35930438 Paper 35894783 Paper 35871325 Paper 35842477 Paper 35816404 Paper 35808984 Paper 35797594 Paper 35768831 Paper 35699222 Paper 35640459 Paper 35551470 Paper 35531707 Paper 35513767 Paper 35513698 Paper 35444054 Paper 35439098 Paper 35413975 Paper 35379992 Paper 35354581 Paper 35351783 Paper 35338450 Paper 35314499 Paper 35253760 Paper 35238936 Paper 35229693 Paper 35213795 Paper 35213382 Paper 35210353 Paper 35204098 Paper 35180114

Abstract

The Pacific Northwest Dementia and Aging (PANDA) Neuropathology (NP) Group is a cooperative effort between the Alzheimer's Disease (AD) Center (ADC) at Oregon Health & Science University (OHSU) and the AD Research Center (ADRC) at the University of Washington (UW) that was initiated in July 2003. The initial four Specific Aims of the PANDA NP Group are unchanged from our previous applications: 1. Provide diagnostic expertise to the diverse population of the Pacific Northwest by providing family members of the deceased and physicians involved in their care with timely autopsy reports based on the most current standardized diagnostic criteria. 2. Facilitate research by collecting, storing and distributing a highly accessible, but appropriately safeguarded, repository of well-prepared brain tissue and neuropathologic data from carefully and longitudinally characterized patients with mild cognitive impairment (MCI) or dementia as well as noncognitively impaired control individuals using a variety of methods that maximizes utility to scientists. 3. Teach trainees in pathology, neurology, psychology, psychiatry, and basic sciences the current methods of neuropathological classification of neurodegenerative diseases and age-related changes, and mentor junior faculty in NP. 4. Develop innovative new approaches to maximize achievements in Aims 1 to 3. Two new Specific Aims are focused on Targeted Molecular Testing: 5. Quantify targeted cerebrospinal fluid (CSF) biomarkers in the UW ADRC CSF Bank that derives in large part from the OHSU ADC and UW ADRC Clinical Cores to enhance the value of these specimens for research while insuring proper safeguards. 6. Provide expert preparation of DNA and targeted genetic testing relevant to AD and related neurodegenerative diseases.

View original record on NIH RePORTER →